Disease Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

ID DOID:3963
Name thyroid gland carcinoma
Definition A thyroid gland cancer that has_material_basis_in epithelial cells.
Source DiseaseOntology.org
Alt Ids
Path disease disease of cellular proliferation cancer organ system cancer endocrine gland cancer thyroid gland cancer thyroid gland carcinoma

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Molecular Profile Therapy Indication/Tumor Type Response Type Profile Response Detail
Unknown unknown Vandetanib thyroid gland carcinoma not applicable detail...
RET C634W Sorafenib thyroid gland carcinoma sensitive detail...
RET C634W Ponatinib thyroid gland carcinoma sensitive detail...
RET M918T Ponatinib thyroid gland carcinoma sensitive detail...
RET C634W Cabozantinib thyroid gland carcinoma sensitive detail...
Unknown unknown Obatoclax thyroid gland carcinoma not applicable detail...
Unknown unknown Sorafenib thyroid gland carcinoma not applicable detail...
Unknown unknown MLN8054 thyroid gland carcinoma not applicable detail...
BRAF V600E PIK3CA H1047R Dabrafenib + Everolimus + Trametinib thyroid gland carcinoma predicted - sensitive detail...
BRAF V600E PIK3CA H1047R Everolimus thyroid gland carcinoma resistant detail...
BRAF V600E PIK3CA H1047R Dabrafenib + Trametinib thyroid gland carcinoma resistant detail...
Clinical Trial Phase Therapies Title Recruitment Status
NCT01208051 Phase Ib/II Cediranib + Lenalidomide Cediranib Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid Cancer Active, not recruiting
NCT01655719 Phase II Pioglitazone Pioglitazone in Thyroid Cancers Completed
NCT02428712 Phase Ib/II PLX8394 A Study of PLX8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors Active, not recruiting
NCT02628067 Phase II Pembrolizumab Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) Recruiting
NCT02834013 Phase 0 Ipilimumab + Nivolumab Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting
NCT03181100 Phase II Atezolizumab + Cobimetinib Atezolizumab + Bevacizumab Atezolizumab + Nab-paclitaxel Atezolizumab + Cobimetinib + Vemurafenib Atezolizumab + Paclitaxel Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer Recruiting
NCT04171622 Phase II Lenvatinib + Pembrolizumab Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer Not yet recruiting